Table 4.
Various laboratory data before and after operation between the two studied groups
| Study group (N = 44) | Control group (N = 41) | Difference 1,2 [95% C.I.] | P | |
|---|---|---|---|---|
| FFA (mmol/L) | ||||
| Day -1 | 0.60 ± 0.35 | 0.65 ± 0.41 | -0.044 [-0.196; 0.108] | 0.566 |
| Day 7 – Day -1 | -0.20 ± 0.38 | -0.03 ± 0.62 | -0.195 [-0.347; -0.042] | 0.013 |
| TG (mg/dL) | ||||
| Day -1 | 97.45 ± 41.12 | 95.06 ± 38.72 | 2.263 [-13.714; 18.239] | 0.779 |
| Day 7 – Day -1 | 20.98 ± 44.85 | 66.69 ± 68.85 | -44.109 [-68.583; -19.634] | <0.001 |
| Cholesterol (mg/mL) | ||||
| Day -1 | 179.22 ± 34.27 | 177.77 ± 39.04 | 1.188 [-13.225; 15.600] | 0.870 |
| Day 7 – Day -1 | -42.61 ± 32.00 | -40.71 ± 34.86 | -2.001 [-13.549; 9.546] | 0.731 |
| LDL (mg/mL) | ||||
| Day -1 | 110.99 ± 23.93 | 109.40 ± 36.00 | 1.660 [-10.504; 13.823] | 0.787 |
| Day 7 – Day -1 | -28.70 ± 25.76 | -27.41 ± 30.50 | -1.350 [-11.281; 8.581] | 0.788 |
| HDL (mg/mL) | ||||
| Day -1 | 37.85 ± 12.62 | 40.57 ± 14.87 | -2.889 [-8.031; 2.254] | 0.268 |
| Day 7 – Day -1 | -12.58 ± 8.70 | -17.36 ± 10.01 | 3.226 [0.796; 5.656] | 0.010 |
| Insulin (mU/L) | ||||
| Day -1 | 14.14 ± 14.96 | 21.80 ± 26.50 | -7.547 [-16.107; 1.013] | 0.083 |
| Day 7 – Day -1 | 22.44 ± 24.68 | 9.80 ± 29.44 | 8.080 [-1.870; 18.029] | 0.110 |
| Glucose (mg/dL) | ||||
| Day -1 | 133.31 ± 57.80 | 128.92 ± 52.68 | 4.840 [-16.791; 26.472] | 0.658 |
| Day 7 – Day -1 | 20.00 ± 47.80 | 29.91 ± 76.32 | -6.656 [-30.295; 16.983] | 0.577 |
| ALT (U/L) | ||||
| Day -1 | 18.65 ± 7.65 | 18.73 ± 12.16 | -0.010 [-3.976; 3.956] | 0.996 |
| Day 7 – Day -1 | 25.35 ± 33.30 | 38.48 ± 43.24 | -11.141 [-26.835; 4.552] | 0.162 |
| AST (U/L) | ||||
| Day -1 | 23.77 ± 11.75 | 23.46 ± 11.80 | 0.325 [-4.394; 5.044] | 0.892 |
| Day 7 – Day -1 | 18.22 ± 34.51 | 24.62 ± 34.26 | -4.523 [-18.384; 9.337] | 0.518 |
| γGT (U/L) | ||||
| Day -1 | 21.88 ± 18.64 | 28.10 ± 47.67 | -5.943 [-20.257; 8.371] | 0.412 |
| Day 7 – Day -1 | 78.27 ± 71.93 | 118.24 ± 112.41 | -36.052 [-73.770; 1.667] | 0.061 |
| Albumin (g/dL) | ||||
| Day -1 | 3.98 ± 0.47 | 4.01 ± 0.46 | -0.035 [-0.194; 0.124] | 0.662 |
| Day 7 – Day -1 | -0.42 ± 0.38 | -0.51 ± 0.39 | 0.099 [-0.038; 0.236] | 0.153 |
| Bilirubin (mg/dL) | ||||
| Day -1 | 0.15 ± 0.10 | 0.15 ± 0.08 | 0.002 [-0.034; 0.037] | 0.929 |
| Day 7 – Day -1 | 0.04 ± 0.26 | 0.09 ± 0.33 | -0.052 [-0.171; 0.067] | 0.389 |
| Leukocyte (103/μL) | ||||
| Day -1 | 5.91 ± 2.52 | 8.00 ± 12.85 | -2.121 [-5.764; 1.522] | 0.251 |
| Day 7 – Day -1 | 28.41 ± 174.51 | 0.67 ± 14.01 | 23.872 [-31.335; 79.079] | 0.392 |
FFA: free fatty acid; TG: triglyceride; LDL: low density lipoprotein; HDL: high density lipoprotein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; γGT; gamma-glutamyl transpeptidase.
1Difference = [study group] - [control group].
2ANOVA incorporating center effect and their respective baseline as covariate; Difference and 95% C.I. was based on the LS-mean.